Related Experiment Video
Updated: Oct 12, 2025

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models
Published on: December 9, 2016
The Long Non-Coding RNA SAMMSON Is a Regulator of Chemosensitivity and Metabolic Orientation in MCF-7
Charlotte Orre1, Xavier Dieu1,2, Jordan Guillon3
1Mitolab Team, Inserm U1083, CNRS 6015, Mito Vasc Institute, SFR ICAT, Angers University, F-49000 Angers, France.
Abstract:
Despite improvements in therapeutic strategies for treating breast cancers, tumor relapse and chemoresistance remain major issues in patient outcomes. Indeed, cancer cells display a metabolic plasticity allowing a quick adaptation to the tumoral microenvironment and to cellular stresses induced by chemotherapy. Recently, long non-coding RNA molecules (lncRNAs) have emerged as important regulators of cellular metabolic orientation. In the present study, we addressed the role of the long non-coding RNA molecule (lncRNA) SAMMSON on the metabolic reprogramming and chemoresistance of MCF-7 breast cancer cells resistant to doxorubicin (MCF-7dox). Our results showed an overexpression of SAMMSON in MCF-7dox compared to doxorubicin-sensitive cells (MCF-7). Silencing of SAMMSON expression by siRNA in MCF-7dox cells resulted in a metabolic rewiring with improvement of oxidative metabolism, decreased mitochondrial ROS production, increased mitochondrial replication, transcription and translation and an attenuation of chemoresistance. These results highlight the role of SAMMSON in the metabolic adaptations leading to the development of chemoresistance in breast cancer cells. Thus, targeting SAMMSON expression levels represents a promising therapeutic route to circumvent doxorubicin resistance in breast cancers.
Insights
Long non-coding RNA SAMMSON promotes breast cancer chemoresistance by altering cell metabolism. Silencing SAMMSON in resistant cells restored sensitivity and improved oxidative metabolism, suggesting SAMMSON as a therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Metabolism
Background:
- Breast cancer treatment faces challenges with tumor relapse and chemoresistance.
- Cancer cells exhibit metabolic plasticity, aiding adaptation to therapy and microenvironment.
- Long non-coding RNAs (lncRNAs) are emerging as key regulators of cellular metabolism.
Purpose of the Study:
- To investigate the role of the lncRNA SAMMSON in metabolic reprogramming.
- To determine SAMMSON's impact on doxorubicin resistance in breast cancer cells (MCF-7dox).
- To explore SAMMSON as a potential therapeutic target for overcoming chemoresistance.
Main Methods:
- Overexpression analysis of SAMMSON in doxorubicin-resistant MCF-7dox cells compared to sensitive MCF-7 cells.
- Silencing of SAMMSON using small interfering RNA (siRNA) in MCF-7dox cells.
- Assessment of metabolic changes, including oxidative metabolism and mitochondrial function.
- Evaluation of chemoresistance levels after SAMMSON manipulation.
Main Results:
- SAMMSON was significantly overexpressed in doxorubicin-resistant MCF-7dox cells.
- siRNA-mediated silencing of SAMMSON led to metabolic rewiring in MCF-7dox cells.
- Key metabolic improvements included enhanced oxidative metabolism, reduced mitochondrial reactive oxygen species (ROS), and increased mitochondrial replication, transcription, and translation.
- Attenuation of doxorubicin resistance was observed following SAMMSON silencing.
Conclusions:
- SAMMSON plays a critical role in the metabolic adaptations that drive chemoresistance in breast cancer.
- Targeting SAMMSON expression offers a promising strategy to overcome doxorubicin resistance.
- Modulating SAMMSON could be a novel therapeutic approach for breast cancer patients experiencing treatment failure.
Related Concept Videos
lncRNA - Long Non-coding RNAs
MicroRNAs
Translational Regulation
Treatment Resistant Cancers
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...

